Development of Chimeric Gene Regulators for Cancer-specific Gene Therapy with both Transcriptional and Translational Targeting

Yu Xiang Fang,Xiao Bo Zhang,Wei Wei,Yi Wen Liu,Jin Zhong Chen,Jing Lun Xue,Ling Tian

DOI: https://doi.org/10.1007/s12033-010-9244-y

2010-01-01

Molecular Biotechnology

Abstract:Cancer gene therapy has been of great challenge in achieving maximal high levels of specificity and more rational efficiency in target cancer cell. We herein developed a novel approach for cancer-specific gene therapy using both transcriptional and translational targeting regulation. We integrated the tumor-specific gene promoter of hTERT, the 5′UTR of bFGF-2, the enhancer of woodchuck hepatitis virus post-transcriptional regulatory element (WRE), and/or the 3′UTR of the human EGFR into two major chimeric gene regulators. We found that chimeric gene regulator I (hTERT_5′UTR···WRE_BGHpolyA) enhanced the specificity of expression in hepatocellular carcinoma (HCC) cells up to 300% in total due to increases at both the transcriptional and translational levels but only 120–200% enhancement at the transcriptional level and 120–180% enhancement at the translational level. In addition, chimeric gene regulator II (hTERT_5′UTR···WRE_3′UTR_BGHpolyA) improved the specificity to 550% and also highly strengthened the stability of the mRNA. In vitro cytotoxicity assays demonstrated that HCC cell growth was inhibited by HSV-1 TK expression under the control of both chimeric regulators, with a relative cell viability of ~80% for 2 days and ~85% for 4 days after transfection, respectively. These observations represent a new approach for highly tumor-specific gene expression and also provide insights into application to cancer gene therapy.